References
[1] N. Wentzensen et al. , “Ovarian Cancer Risk Factors by
Histologic Subtype: An Analysis From the Ovarian Cancer Cohort
Consortium,” J Clin Oncol , vol. 34, no. 24, pp. 2888–2898, Aug.
2016, doi: 10.1200/JCO.2016.66.8178.
[2] S. Lheureux, C. Gourley, I. Vergote, and A. M. Oza, “Epithelial
ovarian cancer,” Lancet , vol. 393, no. 10177, pp. 1240–1253,
Mar. 2019, doi: 10.1016/S0140-6736(18)32552-2.
[3] P. Gaona-Luviano, L. A. Medina-Gaona, and K. Magaña-Pérez,
“Epidemiology of ovarian cancer,” Chin Clin Oncol , vol. 9, no.
4, p. 47, Aug. 2020, doi: 10.21037/cco-20-34.
[4] L. Baandrup, M. T. Faber, G. L. Aalborg, and S. K. Kjaer,
“Borderline ovarian tumors in Denmark 1997-2018: Time trends in
incidence by histology, age and educational level,” Acta Obstet
Gynecol Scand , vol. 100, no. 3, pp. 436–443, Mar. 2021, doi:
10.1111/aogs.14013.
[5] A. C. Y. Leung et al. , “Tea, coffee, and caffeinated
beverage consumption and risk of epithelial ovarian cancers,”Cancer Epidemiol , vol. 45, pp. 119–125, Dec. 2016, doi:
10.1016/j.canep.2016.10.010.
[6] H. Kuper, L. Titus-Ernstoff, B. L. Harlow, and D. W. Cramer,
“Population based study of coffee, alcohol and tobacco use and risk of
ovarian cancer,” Int J Cancer , vol. 88, no. 2, pp. 313–318,
Oct. 2000, doi:
10.1002/1097-0215(20001015)88:2<313::aid-ijc26>3.0.co;2-5.
[7] C. F. Gosvig, S. K. Kjaer, J. Blaakær, E. Høgdall, C. Høgdall,
and A. Jensen, “Coffee, tea, and caffeine consumption and risk of
epithelial ovarian cancer and borderline ovarian tumors: Results from a
Danish case-control study,” Acta Oncol , vol. 54, no. 8, pp.
1144–1151, 2015, doi: 10.3109/0284186X.2014.1001035.
[8] N. A. Lueth, K. E. Anderson, L. J. Harnack, J. A. Fulkerson, and
K. Robien, “Coffee and caffeine intake and the risk of ovarian cancer:
the Iowa Women’s Health Study,” Cancer Causes Control , vol. 19,
no. 10, pp. 1365–1372, Dec. 2008, doi: 10.1007/s10552-008-9208-8.
[9] A. Khodavandi, F. Alizadeh, and A. F. A. Razis, “Association
between dietary intake and risk of ovarian cancer: a systematic review
and meta-analysis,” Eur J Nutr , vol. 60, no. 4, pp. 1707–1736,
Jun. 2021, doi: 10.1007/s00394-020-02332-y.
[10] R. G. Biesma, L. J. Schouten, M. J. M. Dirx, R. A. Goldbohm,
and P. A. van den Brandt, “Physical activity and risk of ovarian
cancer: results from the Netherlands Cohort Study (The Netherlands),”Cancer Causes Control , vol. 17, no. 1, pp. 109–115, Feb. 2006,
doi: 10.1007/s10552-005-0422-3.
[11] M. F. Leitzmann et al. , “Prospective study of physical
activity and the risk of ovarian cancer,” Cancer Causes Control ,
vol. 20, no. 5, pp. 765–773, Jul. 2009, doi: 10.1007/s10552-008-9291-x.
[12] J. Lee, “Physical activity, sitting time, and the risk of
ovarian cancer: A brief research report employing a meta-analysis of
existing,” Health Care Women Int , vol. 40, no. 4, pp. 433–458,
Apr. 2019, doi: 10.1080/07399332.2018.1505892.
[13] A. Grundy et al. , “Lifetime recreational
moderate-to-vigorous physical activity and ovarian cancer risk: A
case-control study,” Int J Cancer , vol. 146, no. 7, pp.
1800–1809, Apr. 2020, doi: 10.1002/ijc.32513.
[14] C. M. Olsen et al. , “Obesity and risk of ovarian cancer
subtypes: evidence from the Ovarian Cancer Association Consortium,”Endocr Relat Cancer , vol. 20, no. 2, pp. 251–262, Apr. 2013,
doi: 10.1530/ERC-12-0395.
[15] J.-S. Ong et al. , “Evaluating the role of alcohol
consumption in breast and ovarian cancer susceptibility using
population-based cohort studies and two-sample Mendelian randomization
analyses,” Int J Cancer , vol. 148, no. 6, pp. 1338–1350, Mar.
2021, doi: 10.1002/ijc.33308.
[16] M. T. Goodman and K. H. Tung, “Alcohol consumption and the
risk of borderline and invasive ovarian cancer,” Obstet Gynecol ,
vol. 101, no. 6, pp. 1221–1228, Jun. 2003, doi:
10.1016/s0029-7844(03)00050-4.
[17] I. Licaj, B. K. Jacobsen, R. M. Selmer, G. Maskarinec, E.
Weiderpass, and I. T. Gram, “Smoking and risk of ovarian cancer by
histological subtypes: an analysis among 300 000 Norwegian women,”Br J Cancer , vol. 116, no. 2, pp. 270–276, Jan. 2017, doi:
10.1038/bjc.2016.418.
[18] S. Hurley, D. Goldberg, L. Bernstein, and P. Reynolds, “Sleep
duration and cancer risk in women,” Cancer Causes Control , vol.
26, no. 7, pp. 1037–1045, Jul. 2015, doi: 10.1007/s10552-015-0579-3.
[19] X. Liang et al. , “Sleep Characteristics and Risk of
Ovarian Cancer Among Postmenopausal Women,” Cancer Prev Res
(Phila) , vol. 14, no. 1, pp. 55–64, Jan. 2021, doi:
10.1158/1940-6207.CAPR-20-0174.
[20] G. Davey Smith and G. Hemani, “Mendelian randomization:
genetic anchors for causal inference in epidemiological studies,”Hum Mol Genet , vol. 23, no. R1, pp. R89-98, Sep. 2014, doi:
10.1093/hmg/ddu328.
[21] N. M. Davies, M. V. Holmes, and G. Davey Smith, “Reading
Mendelian randomisation studies: a guide, glossary, and checklist for
clinicians,” BMJ , vol. 362, p. k601, Jul. 2018, doi:
10.1136/bmj.k601.
[22] J. J. Lee et al. , “Gene discovery and polygenic
prediction from a genome-wide association study of educational
attainment in 1.1 million individuals,” Nat Genet , vol. 50, no.
8, pp. 1112–1121, Jul. 2018, doi: 10.1038/s41588-018-0147-3.
[23] V. W. Zhong et al. , “A genome-wide association study of
bitter and sweet beverage consumption,” Hum Mol Genet , vol. 28,
no. 14, pp. 2449–2457, Jul. 2019, doi: 10.1093/hmg/ddz061.
[24] S. F. W. Meddens et al. , “Genomic analysis of diet
composition finds novel loci and associations with health and
lifestyle,” Mol Psychiatry , vol. 26, no. 6, pp. 2056–2069, Jun.
2021, doi: 10.1038/s41380-020-0697-5.
[25] S. L. Pulit et al. , “Meta-analysis of genome-wide
association studies for body fat distribution in 694 649 individuals of
European ancestry,” Hum Mol Genet , vol. 28, no. 1, pp. 166–174,
Jan. 2019, doi: 10.1093/hmg/ddy327.
[26] Y. C. Klimentidis et al. , “Genome-wide association
study of habitual physical activity in over 377,000 UK Biobank
participants identifies multiple variants including CADM2 and APOE,”Int J Obes (Lond) , vol. 42, no. 6, pp. 1161–1176, Jun. 2018,
doi: 10.1038/s41366-018-0120-3.
[27] M. Liu et al. , “Association studies of up to 1.2
million individuals yield new insights into the genetic etiology of
tobacco and alcohol use,” Nat Genet , vol. 51, no. 2, pp.
237–244, Feb. 2019, doi: 10.1038/s41588-018-0307-5.
[28] R. E. Wootton et al. , “Evidence for causal effects of
lifetime smoking on risk for depression and schizophrenia: a Mendelian
randomisation study,” Psychol Med , vol. 50, no. 14, pp.
2435–2443, Oct. 2020, doi: 10.1017/S0033291719002678.
[29] H. S. Dashti et al. , “Genome-wide association study
identifies genetic loci for self-reported habitual sleep duration
supported by accelerometer-derived estimates,” Nat Commun , vol.
10, no. 1, p. 1100, Mar. 2019, doi: 10.1038/s41467-019-08917-4.
[30] P. R. Jansen et al. , “Genome-wide analysis of insomnia
in 1,331,010 individuals identifies new risk loci and functional
pathways,” Nat Genet , vol. 51, no. 3, pp. 394–403, Mar. 2019,
doi: 10.1038/s41588-018-0333-3.
[31] C. M. Phelan et al. , “Identification of 12 new
susceptibility loci for different histotypes of epithelial ovarian
cancer,” Nat Genet , vol. 49, no. 5, pp. 680–691, May 2017, doi:
10.1038/ng.3826.
[32] G. Hemani et al. , “The MR-Base platform supports
systematic causal inference across the human phenome,” Elife ,
vol. 7, p. e34408, May 2018, doi: 10.7554/eLife.34408.
[33] S. Burgess, A. Butterworth, and S. G. Thompson, “Mendelian
randomization analysis with multiple genetic variants using summarized
data,” Genet Epidemiol , vol. 37, no. 7, pp. 658–665, Nov. 2013,
doi: 10.1002/gepi.21758.
[34] J. Bowden, G. Davey Smith, P. C. Haycock, and S. Burgess,
“Consistent Estimation in Mendelian Randomization with Some Invalid
Instruments Using a Weighted Median Estimator,” Genet Epidemiol ,
vol. 40, no. 4, pp. 304–314, May 2016, doi: 10.1002/gepi.21965.
[35] J. Bowden, G. Davey Smith, and S. Burgess, “Mendelian
randomization with invalid instruments: effect estimation and bias
detection through Egger regression,” Int J Epidemiol , vol. 44,
no. 2, pp. 512–525, Apr. 2015, doi: 10.1093/ije/dyv080.
[36] M. Verbanck, C.-Y. Chen, B. Neale, and R. Do, “Detection of
widespread horizontal pleiotropy in causal relationships inferred from
Mendelian randomization between complex traits and diseases,” Nat
Genet , vol. 50, no. 5, pp. 693–698, May 2018, doi:
10.1038/s41588-018-0099-7.
[37] O. O. Yavorska and S. Burgess, “MendelianRandomization: an R
package for performing Mendelian randomization analyses using summarized
data,” Int J Epidemiol , vol. 46, no. 6, pp. 1734–1739, Dec.
2017, doi: 10.1093/ije/dyx034.
[38] S. Yuan, Y. Xiong, M. Michaëlsson, K. Michaëlsson, and S. C.
Larsson, “Genetically predicted education attainment in relation to
somatic and mental health,” Sci Rep , vol. 11, no. 1, p. 4296,
Feb. 2021, doi: 10.1038/s41598-021-83801-0.
[39] M. T. Goodman, K.-H. Tung, K. McDuffie, L. R. Wilkens, and T.
A. Donlon, “Association of caffeine intake and CYP1A2 genotype with
ovarian cancer,” Nutr Cancer , vol. 46, no. 1, pp. 23–29, 2003,
doi: 10.1207/S15327914NC4601_03.
[40] “Caffeine, alcohol, smoking, and the risk of incident
epithelial ovarian cancer - PubMed.”
https://pubmed.ncbi.nlm.nih.gov/18213613/ (accessed Apr. 10, 2022).
[41] J. Kotsopoulos et al. , “Coffee intake, variants in
genes involved in caffeine metabolism, and the risk of epithelial
ovarian cancer,” Cancer Causes Control , vol. 20, no. 3, pp.
335–344, Apr. 2009, doi: 10.1007/s10552-008-9247-1.
[42] Y. J. Song, A. R. Kristal, K. G. Wicklund, K. L.
Cushing-Haugen, and M. A. Rossing, “Coffee, tea, colas, and risk of
epithelial ovarian cancer,” Cancer Epidemiol Biomarkers Prev ,
vol. 17, no. 3, pp. 712–716, Mar. 2008, doi:
10.1158/1055-9965.EPI-07-2511.
[43] R. Arthur, V. A. Kirsh, and T. E. Rohan, “Associations of
coffee, tea and caffeine intake with risk of breast, endometrial and
ovarian cancer among Canadian women,” Cancer Epidemiol , vol. 56,
pp. 75–82, Oct. 2018, doi: 10.1016/j.canep.2018.07.013.
[44] M. Hashibe et al. , “Coffee, tea, caffeine intake, and
the risk of cancer in the PLCO cohort,” Br J Cancer , vol. 113,
no. 5, pp. 809–816, Sep. 2015, doi: 10.1038/bjc.2015.276.
[45] S. J. Jordan, D. M. Purdie, A. C. Green, and P. M. Webb,
“Coffee, tea and caffeine and risk of epithelial ovarian cancer,”Cancer Causes Control , vol. 15, no. 4, pp. 359–365, May 2004,
doi: 10.1023/B:CACO.0000027482.00077.8b.
[46] S.-Y. Park, N. D. Freedman, C. A. Haiman, L. Le Marchand, L. R.
Wilkens, and V. W. Setiawan, “Prospective Study of Coffee Consumption
and Cancer Incidence in Non-White Populations,” Cancer Epidemiol
Biomarkers Prev , vol. 27, no. 8, pp. 928–935, Aug. 2018, doi:
10.1158/1055-9965.EPI-18-0093.
[47] K. Hirose, Y. Niwa, K. Wakai, K. Matsuo, T. Nakanishi, and K.
Tajima, “Coffee consumption and the risk of endometrial cancer:
Evidence from a case-control study of female hormone-related cancers in
Japan,” Cancer Sci , vol. 98, no. 3, pp. 411–415, Mar. 2007,
doi: 10.1111/j.1349-7006.2007.00391.x.
[48] C. M. Nagle, C. M. Olsen, C. J. Bain, D. C. Whiteman, A. C.
Green, and P. M. Webb, “Tea consumption and risk of ovarian cancer,”Cancer Causes Control , vol. 21, no. 9, pp. 1485–1491, Sep. 2010,
doi: 10.1007/s10552-010-9577-7.
[49] R. B. Ness, “Endometriosis and ovarian cancer: thoughts on
shared pathophysiology,” Am J Obstet Gynecol , vol. 189, no. 1,
pp. 280–294, Jul. 2003, doi: 10.1067/mob.2003.408.
[50] R. L. Ferrini and E. Barrett-Connor, “Caffeine intake and
endogenous sex steroid levels in postmenopausal women. The Rancho
Bernardo Study,” Am J Epidemiol , vol. 144, no. 7, pp. 642–644,
Oct. 1996, doi: 10.1093/oxfordjournals.aje.a008975.
[51] C. Nagata, M. Kabuto, and H. Shimizu, “Association of coffee,
green tea, and caffeine intakes with serum concentrations of estradiol
and sex hormone-binding globulin in premenopausal Japanese women,”Nutr Cancer , vol. 30, no. 1, pp. 21–24, 1998, doi:
10.1080/01635589809514635.
[52] F. Parazzini, P. Viganò, M. Candiani, and L. Fedele, “Diet and
endometriosis risk: a literature review,” Reprod Biomed Online ,
vol. 26, no. 4, pp. 323–336, Apr. 2013, doi:
10.1016/j.rbmo.2012.12.011.
[53] W. Qiu, H. Lu, Y. Qi, and X. Wang, “Dietary fat intake and
ovarian cancer risk: a meta-analysis of epidemiological studies,”Oncotarget , vol. 7, no. 24, pp. 37390–37406, Jun. 2016, doi:
10.18632/oncotarget.8940.
[54] M. A. Merritt, D. W. Cramer, S. A. Missmer, A. F. Vitonis, L.
J. Titus, and K. L. Terry, “Dietary fat intake and risk of epithelial
ovarian cancer by tumour histology,” Br J Cancer , vol. 110, no.
5, pp. 1392–1401, Mar. 2014, doi: 10.1038/bjc.2014.16.
[55] Collaborative Group on Epidemiological Studies of Ovarian
Cancer, “Ovarian cancer and body size: individual participant
meta-analysis including 25,157 women with ovarian cancer from 47
epidemiological studies,” PLoS Med , vol. 9, no. 4, p. e1001200,
2012, doi: 10.1371/journal.pmed.1001200.
[56] J. Yarmolinsky et al. , “Appraising the role of
previously reported risk factors in epithelial ovarian cancer risk: A
Mendelian randomization analysis,” PLoS Med , vol. 16, no. 8, p.
e1002893, Aug. 2019, doi: 10.1371/journal.pmed.1002893.
[57] S. C. Dixon et al. , “Adult body mass index and risk of
ovarian cancer by subtype: a Mendelian randomization study,” Int
J Epidemiol , vol. 45, no. 3, pp. 884–895, Jun. 2016, doi:
10.1093/ije/dyw158.
[58] S. Jordan, A. Green, and P. Webb, “Benign epithelial ovarian
tumours-cancer precursors or markers for ovarian cancer risk?,”Cancer Causes Control , vol. 17, no. 5, pp. 623–632, Jun. 2006,
doi: 10.1007/s10552-005-0370-y.
[59] S. J. Jordan, A. C. Green, D. C. Whiteman, and P. M. Webb,
“Risk factors for benign serous and mucinous epithelial ovarian
tumors,” Obstet Gynecol , vol. 109, no. 3, pp. 647–654, Mar.
2007, doi: 10.1097/01.AOG.0000254159.75977.fa.
[60] C. M. Olsen et al. , “Recreational physical activity and
epithelial ovarian cancer: a case-control study, systematic review, and
meta-analysis,” Cancer Epidemiol Biomarkers Prev , vol. 16, no.
11, pp. 2321–2330, Nov. 2007, doi: 10.1158/1055-9965.EPI-07-0566.
[61] L.-M. Zhou, “Recreational physical activity and risk of
ovarian cancer: a meta-analysis,” Asian Pac J Cancer Prev , vol.
15, no. 13, pp. 5161–5166, 2014, doi: 10.7314/apjcp.2014.15.13.5161.
[62] J. S. Hildebrand, S. M. Gapstur, M. M. Gaudet, P. T. Campbell,
and A. V. Patel, “Moderate-to-vigorous physical activity and
leisure-time sitting in relation to ovarian cancer risk in a large
prospective US cohort,” Cancer Causes Control , vol. 26, no. 11,
pp. 1691–1697, Nov. 2015, doi: 10.1007/s10552-015-0656-7.
[63] M. A. Rossing, K. L. Cushing-Haugen, K. G. Wicklund, J. A.
Doherty, and N. S. Weiss, “Recreational physical activity and risk of
epithelial ovarian cancer,” Cancer Causes Control , vol. 21, no.
4, pp. 485–491, Apr. 2010, doi: 10.1007/s10552-009-9479-8.
[64] M. T. Faber et al. , “Cigarette smoking and risk of
ovarian cancer: a pooled analysis of 21 case-control studies,”Cancer Causes Control , vol. 24, no. 5, pp. 989–1004, May 2013,
doi: 10.1007/s10552-013-0174-4.
[65] Collaborative Group on Epidemiological Studies of Ovarian
Cancer et al. , “Ovarian cancer and smoking: individual
participant meta-analysis including 28,114 women with ovarian cancer
from 51 epidemiological studies,” Lancet Oncol , vol. 13, no. 9,
pp. 946–956, Sep. 2012, doi: 10.1016/S1470-2045(12)70322-4.
[66] “Wine and other alcohol consumption and risk of ovarian cancer
in the California Teachers Study cohort - PubMed.”
https://pubmed.ncbi.nlm.nih.gov/17186425/ (accessed Apr. 11, 2022).
[67] N. B. Peterson et al. , “Alcohol consumption and ovarian
cancer risk in a population-based case-control study,” Int J
Cancer , vol. 119, no. 10, pp. 2423–2427, Nov. 2006, doi:
10.1002/ijc.22137.
[68] S. S. Tworoger, D. M. Gertig, M. A. Gates, J. L. Hecht, and S.
E. Hankinson, “Caffeine, alcohol, smoking, and the risk of incident
epithelial ovarian cancer,” Cancer , vol. 112, no. 5, pp.
1169–1177, Mar. 2008, doi: 10.1002/cncr.23275.
[69] L. J. Schouten, M. P. A. Zeegers, R. A. Goldbohm, and P. A. van
den Brandt, “Alcohol and ovarian cancer risk: results from the
Netherlands Cohort Study,” Cancer Causes Control , vol. 15, no.
2, pp. 201–209, Mar. 2004, doi: 10.1023/B:CACO.0000019512.71560.2b.
[70] C. La Vecchia, E. Negri, S. Franceschi, F. Parazzini, A.
Gentile, and M. Fasoli, “Alcohol and epithelial ovarian cancer,”J Clin Epidemiol , vol. 45, no. 9, pp. 1025–1030, Sep. 1992, doi:
10.1016/0895-4356(92)90119-8.
[71] L. E. Kelemen, T. A. Sellers, R. A. Vierkant, L. Harnack, and
J. R. Cerhan, “Association of folate and alcohol with risk of ovarian
cancer in a prospective study of postmenopausal women,” Cancer
Causes Control , vol. 15, no. 10, pp. 1085–1093, Dec. 2004, doi:
10.1007/s10552-004-1546-6.
[72] P. M. Webb, D. M. Purdie, C. J. Bain, and A. C. Green,
“Alcohol, wine, and risk of epithelial ovarian cancer,” Cancer
Epidemiol Biomarkers Prev , vol. 13, no. 4, pp. 592–599, Apr. 2004.